Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers
Status:
Completed
Trial end date:
2019-10-25
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term plasma and urine pharmacokinetic
parameters of Cardionat®, capsules 250 mg, when used in healthy athlete volunteers.
The study consists of four steps:
- Step 1. Screening - selecting healthy volunteers for inclusion in the study;
- Step 2. Assignment in one of the study group, prescription of the study drug;
- Step 3. Samples collections for pharmacokinetic analysis;
- Step 4. Evaluation of pharmacokinetic data.